Introduction
============

Health guidelines recommend aerobic exercise training for improving cardiorespiratory fitness (CRF) and reducing the risk of chronic disease and premature mortality ([@B66]; [@B56]). An increase of one metabolic equivalent (3.5 mL/kg/min) results in a 10--25% improvement in survival over an approximate 10-year follow-up ([@B10]; [@B26]; [@B44]; [@B45]; [@B46]). There are various forms of aerobic exercise training that can be differentiated by their intensity and duration. Moderate Intensity Continuous Training (MICT) generally consists of 30--60 min of aerobic exercise at 64--76% peak heart rate ([@B1]), while interval training involves more intense bouts interspersed by recovery periods ([@B65]). Interval training can be separated based on intensity into High-Intensity Interval Training (HIIT) or Sprint Interval Training (SIT). HIIT can be further defined by volume. Although classically associated with weekly loads in athletes, volume has gained acceptance to define the total duration of HIIT interval lengths ([@B15]; [@B59]; [@B53]; [@B20]; [@B55]). High-volume High-Intensity Interval Training (HIIT) typically includes repeated intervals of near maximal aerobic efforts for a specific period (e.g., 4 × 4-minute intervals at 90% peak heart rate), with a rest/recovery period in between (e.g., 3 min at 65% peak heart rate). Low-volume HIIT has fewer or shorter intervals (e.g., 6 × 1-minute intervals at 120% peak work rate) and SIT is defined as supramaximal exertion (e.g., 8 × 20-second intervals at 170% peak work rate) with active recovery/rest between intervals. Interval training has recently become popular because it is more time efficient ([@B49]), and sometimes more enjoyable than MICT ([@B8]; [@B35]).

Meta-analyses have shown that high-volume HIIT is comparable, if not superior, to MICT for improving CRF (![](fphys-10-00019-i001.jpg)O~2max~/![](fphys-10-00019-i001.jpg)O~2peak~) and other health biomarkers ([@B25]; [@B65]; [@B42]; [@B52]; [@B9]). High-volume HIIT produces greater ![](fphys-10-00019-i001.jpg)O~2max~/![](fphys-10-00019-i001.jpg)O~2peak~ changes than low-volume HIIT and SIT protocols at the group level ([@B4]; [@B2]; [@B25]; [@B42]); where ![](fphys-10-00019-i001.jpg)O~2max~ is a maximal effort on graded exercise test with a plateau in oxygen consumption, and ![](fphys-10-00019-i001.jpg)O~2peak~ is a maximal effort on a graded exercise test without a plateau in oxygen consumption ([@B16]). However, there is heterogeneity in the observed CRF response to an exercise intervention (i.e., the "trainability" of an individual). Some individuals show large improvements in CRF (often described as "responders"), whereas others show little to no-improvements ("low-responders") following the same apparent exercise training stimulus ([@B4]; [@B2]; [@B16]; [@B40]; [@B14]). Optimizing exercise training to improve CRF is imperative to long-term health; therefore, it is important to understand how factors such as the type of aerobic exercise intervention can influence observed rates of CRF trainability.

In the largest study to date on CRF trainability (The HERITAGE study; *n* = 742), ![](fphys-10-00019-i001.jpg)O~2max~ gain following 20 weeks of endurance training was 400 mL on average, with 7% of participants gaining 100 mL/min or less and 8% gaining 700 mL/min or more ([@B13]). However, this observed heterogeneity in ![](fphys-10-00019-i001.jpg)O~2max~ trainability may have resulted from technical error of measurement (TEM); a combination of random within-individual variation and/or measurement error ([@B3]; [@B28], [@B29]; [@B31]; [@B68]). Furthermore, the variability in training response should consider the minimal clinically important difference (MCID). Without considering the TEM and the MCID, identifying the probability of an individual's response is inconclusive and CRF trainability may be misclassified ([@B3]). Despite this, many studies to-date have used zero-change or a proportion of a group to classify "adverse-responders", "non-responders", "low-responders" and "high responders" to CRF training ([@B58]; [@B40]; [@B27]). Using this terminology based on arbitrary indicators for response is problematic and has created much debate ([@B43]; [@B29]). Some investigators have proposed that the concept of "non-responders" is a myth and that simply increasing the training load converts the majority of "non-responders" to "responders" ([@B4]; [@B34]; [@B43]). Training load considers both the intensity and duration of exercise ([@B5]). Recently, [@B32], [@B33]) found that the number of non-responders is minimal if the intensity and duration of training is high enough. Individuals were able to generate a higher stroke volume and cardiac output ([@B32], [@B33]), both of which are imperative for increasing the ability of the heart to improve ![](fphys-10-00019-i001.jpg)O2max ([@B38]).

The primary aim of this study was to utilize a large multi-center approach (*n* = 677 participants across 18 studies) to compare the number of likely responders between different training loads: high-volume HIIT, low-volume HIIT/SIT, and MICT interventions. In this study, we have taken into account the TEM and the MCID to categorize participants as either a "likely responder", "likely non-responder", "likely adverse responder" or "uncertain". The use of these categories provides information on the spread of participant responses relative to the MCID. Based on the literature to date, we hypothesized that high-volume HIIT will have more likely responders compared to MICT and low-volume HIIT/SIT.

Materials and Methods {#s1}
=====================

Participant Characteristics and Recruiting
------------------------------------------

This study includes the initial results of a larger study (PREDICT-HIIT) examining genetic predictors for ![](fphys-10-00019-i001.jpg)O~2peak~ trainability from HIIT/SIT and MICT interventions. Studies and potential participants were identified by contacts made through university affiliations (i.e., researchers involved in relevant studies). Studies were included if they met the following criteria: (1) participated in a HIIT, SIT, or MICT training study three or more weeks in duration within the last 15 years, (2) had an objective measure of ![](fphys-10-00019-i001.jpg)O~2peak~ (indirect calorimetry from a graded exercise test to volitional fatigue on a cycle ergometer or treadmill) before and after training, and (3) participant DNA collection was possible. Eligibility was open to male and female adults over the age of 18. Participants were included if they had greater than 80% attendance to the supervised protocol. Ethical approval was obtained from the various institutions and by the Bellberry ethical committee at the host institution (\#2016-02-062-A-1).

High Intensity Interval Training (HIIT) and SIT were classified according to the intensity thresholds provided by ([@B65]). High-volume HIIT was further defined as ≥ 15 min of high-intensity efforts in total during the session and low-volume HIIT was defined as \<15 min of high-intensity efforts in total during the session. SIT was classified as repeats of \<1 min above maximal efforts (per bout). MICT was defined as 30 min or more of continuous exercise at 64--76% maximum heart rate (HR ~max~) or equivalent. For analysis purposes, low-volume HIIT and SIT studies were combined because their training loads were similar. Training loads were based on Edwards' training impulse (TRIMP); time in each training heart rate zone multiplied by the relative weighting factor of exercise intensity ([@B19]).

Data Analysis
-------------

Normality and homoscedasticity for ![](fphys-10-00019-i001.jpg)O~2peak~ response were assessed using the Shapiro--Wilk and Levene's tests. Data are presented as mean ± standard deviation where appropriate. We used a paired sample *t*-test to calculate the group mean ![](fphys-10-00019-i001.jpg)O~2peak~ response for high-volume HIIT, low-volume HIIT/SIT and MICT. Effect sizes were based on Cohen's *d*. We used an analysis of covariance (ANCOVA) to compare adjusted relative ![](fphys-10-00019-i001.jpg)O~2peak~ responses between high-volume HIIT, low-volume HIIT/SIT and MICT. Values were adjusted for age, sex, individual study, duration of individual study, number of sessions each week, population group (e.g., coronary artery disease) and the average between pre and post-test scores (to avoid regression to the mean) ([@B6]). The ANCOVA for absolute ![](fphys-10-00019-i001.jpg)O~2peak~ also included baseline weight as a covariate. Ethnicity was not a common identifier across studies and therefore was not included as a covariate. *Post hoc* testing used Tukey's least significance difference test. A regression analysis determined the contribution of the covariates to the ![](fphys-10-00019-i001.jpg)O~2peak~ response. We used an analysis of variance (ANOVA) to compare men and women group mean ![](fphys-10-00019-i001.jpg)O~2peak~ responses within each intervention, and to compare ![](fphys-10-00019-i001.jpg)O~2peak~ responses between population groups. Statistical analyses were completed using SPSS (version 23.0, SPSS Inc., Chicago, IL, United States).

The thresholds for response categories used a combination of the TEM and the MCID. Categories included "likely responder", "likely non-responder", "likely adverse responder" and "uncertain". [Table 1](#T1){ref-type="table"} shows the categories illustrated with an example. Combining the MCID and TEM for the threshold improves the confidence in the "likely responder"/"non responder" classifications (e.g., compared to 2 TEM threshold ([@B29])). The TEMs for each individual study were first estimated by multiplying the mean baseline ![](fphys-10-00019-i001.jpg)O~2peak~ value by a previously published coefficient of variation (CV) for ![](fphys-10-00019-i001.jpg)O~2peak~ of 5.6% ([@B36]). These were then averaged to obtain the TEM for each group that was used in the calculation to categorize individuals. The use of a CV of 5.6% has been suggested by others ([@B29]) and is more conservative than what has been previously used (3.5%) ([@B18]). It has been demonstrated that as little as a 1 mL/kg/min can be clinically important in individuals with coronary artery disease ([@B37]). Despite this, we used 3.5 mL/kg/min as the MCID based on evidence that it is associated with a 10--25% decreased risk of all-cause mortality in studies with an approximate 10-year follow-up ([@B10]; [@B26]; [@B45]; [@B46]). A likely responder was considered a ![](fphys-10-00019-i001.jpg)O2peak response of above one MCID plus the TEM. Individual TEMs were calculated for each study resulting in different thresholds. These individual TEMs were averaged to provide a threshold for each training intervention (high-volume HIIT, low-volume HIIT/SIT and MICT). A likely responder for the high-volume HIIT group was above 5.3 mL/kg/min, low-volume HIIT/SIT group was 5.2 mL/kg/min and MICT group was 5.0 mL/kg/min. A comparison of likely responders between interventions was calculated using Medcalc statistical software, based on the "n-1" Chi-squared test ([@B41]).

###### 

Criteria for the responder categories with examples.

  Category                   Criteria                                            Example if an intervention in a study had a TEM of 5 mL/kg/min and an MCID of 3.5 mL/kg/min
  -------------------------- --------------------------------------------------- ---------------------------------------------------------------------------------------------
  Likely responder           \> 1 TEM above the + MCID                           \> 8.5 mL/kg/min
  Likely non-responder       \> 1 TEM below + MCID to \< 1 TEM below the −MCID   −1.5 mL/kg/min to −8.5 mL/kg/min
  Likely adverse responder   \> 1 TEM below the -MCID                            \< 8.5 mL/kg/min
  Uncertain                  \< 1 TEM above to \< 1 TEM below + MCID             −1.5 mL/kg/min to 8.5 mL/kg/min

Results
=======

In total, 677 participants across 18 studies from eight different universities provided data for this analysis ([Table 2](#T2){ref-type="table"}). These came from the University of Queensland, Australia (*n* = 191), Antwerp University and the Catholic University of Leuven, Belgium (*n* = 180), the Norwegian University of Science and Technology, Norway (*n* = 126), The Gene SMART cohort (PMID: 29143594) at Victoria University, Australia (*n* = 59), Queens University, Canada (*n* = 55), the University of British Columbia, Canada (*n* = 38), and the University of Texas Southwestern Medical Center, United States (*n* = 28).

###### 

Included studies for each intervention.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                           High-volume HIIT                                                                                                                                                                                                                                                                                                                                                                                                                                                            Low-volume HIIT/SIT                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  MICT
  -------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  University of Queensland (UQ)                            Study ([@B54]): *n* = 25 people with metabolic syndrome, 16-wk study, 4 × 4 protocol (38 min total with 16 min high intensity −10 min warm up at 60--70% HR ~peak~, followed by 4x4 min at 85--90% HR~peak~, 3-min recovery in between each set at 50--70% HR ~peak~), 3x/wk. **Training load per session: ¬97 AU**\                                                                                                                                                        Study ([@B54]): *n* = 26 people with metabolic syndrome,16-wk study, 1 × 4 protocol (17 min total with 4 min high intensity −10 min warm up at 50--60% HR ~peak~, 1 × 4 min at 85--95% HR ~peak~, 3 min recovery in between each set at 50--70% HR ~peak~), 3x/wk. **Training load per session: ¬23.5 AU**\                                                                                                                                                                                                                                                                                          Study ([@B54]): *n* = 25 people with metabolic syndrome, 16-wk study, 30 min at 60--70% HR ~peak;~ 5x/wk. **Training load per session: ¬60 AU**\
                                                           Study ([@B61]): *n* = 37 people with CAD, 12-wk study, 4 × 4 protocol (38 min total with 16 min high intensity −10 min warm up at 11--13, followed by 4 × 4 min at 15--18 RPE,~,~ 3-min recovery in between each set at 11--13), 3x/wk. **Training load per session: ¬97 AU**                                                                                                                                                                                               Study (unpublished); *n* = 19 with Type-2 diabetes, 8-wk study, 1x4 protocol (26 min total with 4 min high intensity −3 min warm up and cool down at 50--60% HR ~peak~,1x4 min at 85--95% HR ~peak~) plus 8 × 1 min resistance exercises with 1min recovery between, RPE 17 + , 3x/wk. **Training load per session: ¬50 AU**                                                                                                                                                                                                                                                                         Study ([@B61]): *n* = 39 people with CAD, 12-wk study, 40 min at 11--13 RPE, 3x/week. **Training load per session ¬80**\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Study (unpublished): *n* = 20 people with Type-2 diabetes, 8-wk study, 22 min 30 s at 55--69% HR ~peak~, plus 30 min of moderate intensity resistance exercises × 2/wk (8 exercises, RPE 11--13, 2 sets of 10 repetitions). **Training load per session ¬84.5** AU AND 2x/wk of MICT alone (52.5 min). **Training load per session ¬45 AU**

  Antwerp University/ Catholic University of Leuven        Study ([@B47]): *n* = 89 people with CAD, 12-wk data; 4 × 4 protocol (38 min total with 16 min high intensity −10 min warm up at 50--70% HR ~peak~, followed by 4 × 4 min at 85--95% HR~peak~, 3-min recovery in between each set at 50--70% HR ~peak~), 3x/week, 3x/wk. **Training load per session: ¬97**                                                                                                                                                                 **N/A**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Study ([@B47]): *n* = 91 people with CAD, 12-week data, 47 min at 60--70% HR ~peak~, 3x/week. **Training load per session: ¬94 AU**

  Norwegian University of Science and Technology (NTNU)    Study ([@B60]): *n* = 49 seniors (70 +), 12-mth data, 4 × 4 protocol (38 min total with 16 min high intensity −10 min warm up at 60--70% HR ~peak~, followed by 4 × 4 min at 85--90% HR~peak~, 3-min recovery in between each set at 50--70% HR ~peak~), 3x/week. **Training load per session: ¬97 AU**                                                                                                                                                                     **N/A**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Study ([@B60]): *n* = 77 seniors, 12-month data, 50 min at 60--70% HR ~peak~, 2x/wk. **Training load per session: ¬100**

  Victoria University (VU) the Gene SMART cohort.          Study ([@B69]): *n* = 59 active and healthy males, 4 wk-study, up to 45 min total with 16--28 min high intensity (5 min warm up at 60 W; 8--14 × 2-min intervals at LT power + 40--70% of change in WR peak and power at LT, 1-min recovery periods at 60 W), 3x/wk. **Training load per session: ¬90- 157 AU**                                                                                                                                                             **N/A**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              **N/A**

  Queen's University                                       Study (unpublished): *n* = 12 active and healthy, 4-wk study, 4x4 protocol (38 min total with 16 min high intensity −10 min warm up at 70--75% HR ~peak~, followed by 4 × 4 min at 90--95% HR~peak~, 3-min recovery in between each set at 70--75% HR ~peak~), 3x/week. **Training load per session: ¬97 AU**                                                                                                                                                               Studies ([@B15]; [@B39]; [@B59]; [@B12], [@B11]): *n* = 31 healthy participants, 4--6-wk Tabata protocol, 4 min total and up to 2 min 40 s of high intensity = 8 × 20 s sprints at 170% WR~peak~ with 10-s load-less cycling between, 4x/wk. **Training load per session: ¬20 AU**\                                                                                                                                                                                                                                                                                                                  Study ([@B50]): *n* = 10 active and healthy adults, 4-wk study, 30 min at 65% WR ~peak~, 4x/wk. **Training load per session: ¬60 AU**
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Study ([@B51]): *n* = 2 healthy participants, 3-wk study, up to 24 min total (8--12 × 1-min intervals at 100% WR ~peak~), 4x/wk, 1 min warm-up and recovery load-less cycling between repeats. **Training load: ¬59 AU**                                                                                                                                                                                                                                                                                                                                                                             

  University of British Columbia (UBC)                     **N/A**                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Study ([@B24]): *n* = 34 with Type-2 diabetes, 12-wk study, up to 25 min total exercise with up to 10 min high intensity in total (4--10 × 1 min bursts at 90% HR ~max;~ 1 min recovery between, 3 min warm up and cool down), 3x/week. **Training load per session: ¬40** AU                                                                                                                                                                                                                                                                                                                        **N/A**

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Study ([@B23]): *n* = 4 healthy females, 3-wk study, 3 sessions each wk, up to 25 min in total, with 10 min high intensity. Session 1 = 30-sec all-out cycling sprints with 4 min recovery (progressing from 4 to 6 repeats). **Training load per session**: ¬ **32.5 AU**. Session 2 = 6-s all-out sprints with 24 sec rest (progress from 10 to 20 repeats). **Training load per session: ¬10--20 AU. S**ession 3 = 1 min sprints and recovery (progressing from 8 to 10 repeats). High intensity intervals = 85% W~max~. Recovery intervals = 15% W~max~. **Training load per session: ¬45 AU**   

  University of Texas Southwestern Medical Center (UTSW)   Study ([@B33]): *n* = 28 sedentary middle-aged men and women, 2-y longitudinal study, 4 × 4 protocol^∗^ up to 2x/wk in first 6 mth and 1/wk maintenance. **Training load per session: ¬97 AU**. Base training, 30--60 min, 2 x/wk. **Training load per session: ¬60--120 AU.** MSS lactate training, 30 min, 1x/wk. **Training load per session: ¬120--150 AU**. Recovery training, 30 min, 1x/wk. **Training load per session: ¬60 AU.** Strength training 1--2 days/wk.   **N/A**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              **N/A**

  Total (n)                                                **299**                                                                                                                                                                                                                                                                                                                                                                                                                                                                     **116**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              **262**
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Numbers (n), percentage (%), heart rate (HR), work rate (WR), rating of perceived exertion (RPE), maximal steady state (MSS), Watts (W), lactate threshold (LT)coronary artery disease (CAD), second (s), minutes (min), week (wk), months (mth), year, (y), repetitions (reps), 4 × 4 protocol

∗

(38 min total with 16 min high intensity -- 10 min warm up at 70--75% HR

peak

, followed by 4 × 4 min above 95% HR

peak

, 3-min recovery in between each set at 60--75% HR

peak

). Tabata protocol = 8 × 20 s sprints at 170% WR

peak

with 10-s load-less cycling between, 4x/wk. Training load = (time in each training zone multiplied by relative weighting of exercise intensity), arbitrary units (AU).

Participants were from various populations including those with coronary artery disease (*n* = 256), type-2 diabetes (*n* = 73), the metabolic syndrome (*n* = 76), as well as individuals who were active and healthy (*n* = 118) and individuals middle-aged or over 75 years (*n* = 154). We collated data from females (*n* = 182) and males (*n* = 495). The mean age was 56.3 ± 16.0 years.

Relative ![](fphys-10-00019-i001.jpg)O~2peak~
---------------------------------------------

[Table 3](#T3){ref-type="table"} and [Figure 1](#F1){ref-type="fig"} provide the changes in unadjusted relative ![](fphys-10-00019-i001.jpg)O~2peak~. Group mean relative ![](fphys-10-00019-i001.jpg)O~2peak~ scores significantly increased after all intervention types, with small effect sizes after high-volume HIIT (3.4 mL/kg/min, 95% CI 3.0 to 3.9 mL/kg/min, *P* \< 0.001) Cohen's *d* = 0.3; MICT (2.5 mL/kg/min, 95% CI 2.1 to 3.0 mL/kg/min, *P* \< 0.001) Cohen's *d* = 0.3; and low-volume HIIT/SIT (2.0 mL/kg/min, 95% CI 1.5 to 2.5 mL/kg/min, *P* \< 0.001) Cohen's *d* = 0.2. [Table 4](#T4){ref-type="table"} presents the adjusted group means. A significant group difference (*P* = 0.01) was found with ANCOVA for relative ![](fphys-10-00019-i001.jpg)O~2peak~ response between high-volume HIIT and MICT (0.84 mL/kg/min, 95% CI 0.2 to 1.5 mL/kg/min). There was no significant difference (*P* = 0.09) between high-volume HIIT and low-volume HIIT/SIT (0.78 mL/kg/min, 95% CI −0.13 to 1.67 mL/kg/min). There was no significant difference (*P* = 0.9) between MICT and low-volume HIIT/SIT (−0.06 mL/kg/min, 95% CI −0.89 to 1.02).

![Mean relative ![](fphys-10-00019-i001.jpg)O~2peak~ response following each training intervention (raw data). Boxes contain the median (horizontal line), 25th and 75th percentile (bottom and top of box, respectively), the minimum and maximum response (bottom and top of whiskers). Individual "outliers" are dots above and below whiskers.](fphys-10-00019-g001){#F1}

###### 

Baseline and relative ![](fphys-10-00019-i001.jpg)O~2peak~ response for each individual study, as well as averages for all studies combined.

  Training intervention                                                                            Total *n* (% F)   Age (years)       Baseline BMI (kg/m^2^)   Pre-training ![](fphys-10-00019-i001.jpg)O~2peak~ (mL/kg/min)   Change (Δ) mLkg/min   Δ %        *P*-value (Cohen's *d*)    TEM (mL/kg/min)   Likely responder *n* (%)   Uncertain *n* (%)   Likely non-responder *n* (%)   Likely adverse responder *n* (%)
  ------------------------------------------------------------------------------------------------ ----------------- ----------------- ------------------------ --------------------------------------------------------------- --------------------- ---------- -------------------------- ----------------- -------------------------- ------------------- ------------------------------ ----------------------------------
  **High-volume HIIT total**                                                                       **299 (22)**      **54.3 ± 16.5**   **27.0 ± 4.4**           **31.4 ± 11.0**                                                 **3.4 ± 4.2**         **10.8**   **\< 0.001 (*d* = 0.3)**   **1.8**           **92 (31)**                **98 (33)**         **105 (35)**                   **4 (1)**
  UQ                                                                                                                                                                                                                                                                                                                                                                                        
  \(1\) 4 × 4 × 3/wk, 16 wk ([@B54])                                                               25 (52)           57.4 ± 1.8        32.4 ± 7.2               24.8 ± 5.0                                                      2.9 ± 5.8             11.7       0.02 (*d* = 0.5)           1.4               9 (36)                     4 (16)              11 (44)                        1 (4)
  \(2\) 4 × 4 × 3/wk, 12 wk ([@B61])                                                               37 (14)           66.0 ± 6.7        28.7 ± 3.7               27.3 ± 5.7                                                      2.6 ± 4.0             9.5        \< 0.001 (*d* = 0.4)       1.5               12 (32)                    8 (22)              17 (46)                        0
  Antwerp/Leuven 4 × 4 × 3/wk, 12-wk ([@B47]):                                                     89 (8)            58.3 ± 10.0       28.0 ± 4.4               23.3 ± 5.9                                                      4.9 ± 4.0             21.0       \< 0.001 (*d* = 0.7)       1.6               38 (43)                    28 (32)             21 (24)                        1 (1)
  NTNU                                                                                                                                                                                                                                                                                                                                                                                      
  \(1\) 4 × 4 × 3/wk, 1 year ([@B60])                                                              49 (39)           71.7 ± 1.8        25.3 ± 3.2               31.8 ± 6.7                                                      3.9 ± 4.3             12.3       \< 0.001 (*d* = 0.6)       1.8               17 (35)                    19 (39)             11 (22)                        2 (4)
  VU                                                                                                                                                                                                                                                                                                                                                                                        
  \(1\) 8--14 × 2min × 3/wk, 4 wk ([@B69])                                                         59 (0)            31.0 ± 8.2        25.2 ± 3.2               46.7 ± 7.1                                                      0.1 ± 2.7             0.2        0.053                      2.6               0                          20 (34)             39 (68)                        0
  Queen's                                                                                                                                                                                                                                                                                                                                                                                   
  \(1\) 4 × 4 × 3/wk, 3wk                                                                          12 (50)           22.0 ± 2.2        25.4 ± 4.9               46.7 ± 8.6                                                      2.5 ± 2.6             5.3        \< 0.01 (*d* = 0.3)        2.6               1 (8)                      7 (59)              4 (33)                         0
  UTS                                                                                                                                                                                                                                                                                                                                                                                       
  \(1\) 4 × 4 × 1/wk, base and recovery × 1--2/wk, MSS × 1/wk, strength × 2/wk, 2 years ([@B33])   28 (54)           53.5 ± 4.8        25.6 ± 3.0               28.8 ± 5.0                                                      5.6 ± 2.9             19.4       \< 0.001 (*d* = 1.0)       1.6               15 (53)                    10 (36)             3 (11)                         0
  **Low-volume HIIT/SIT**                                                                          **116 (43)**      **48.1 ± 18.1**   **30.3 ± 6.6**           **30.6 ± 12.8**                                                 **2.0 ± 2.9**         **6.5**    **\< 0.001 (*d* = 0.2)**   **1.7**           **18 (16)**                **37 (32)**         **61 (52)**                    **0**
  UQ                                                                                                                                                                                                                                                                                                                                                                                        
  \(1\) 1 × 4, × 3/wk, 16 wk ([@B54])                                                              26 (35)           57.1 ± 7.4        31.0 ± 5.2               26.5 ± 6.3                                                      2.3 ± 2.7             8.7        \< 0.001 (*d* = 1.0)       1.5               3 (12)                     10 (38)             13 (50)                        0
  \(2\) 1 × 4 + strength × 3/wk, 8 wk                                                              19 (9)            59.5 ± 8.7        34.5 ± 6.1               21.8 ± 4.8                                                      0.7 ± 3.1             1.8        0.4                        1.2               3 (16)                     1 (5)               15 (79)                        0
  Queens                                                                                                                                                                                                                                                                                                                                                                                    
  (1--5) 8 × 20-second sprints, 4x/wk ([@B15]; [@B39]; [@B59]; [@B12], [@B11])                     15 (40)           20.9 ± 1.0        24.8 ± 2.8               44.4 ± 7.1                                                      0.6 ± 3.7             1.5        0.6                        2.5               2 (13)                     3 (20)              10 (67)                        0
  3wk                                                                                              12 (0)            21.5 ± 3.7        24.4 ± 4.5               50.9 ± 9.0                                                      3.8 ± 3.3             7.5        \< 0.01 (*d* = 0.4)        2.9               3 (25)                     7 (58)              2 (17)                         0
  4wk                                                                                              4 (0)             22.0 ± 1.2        25.2 ± 1.5               47.3 ± 6.2                                                      3.1 ± 2.7             6.6        0.1                        2.8               1 (25)                     3 (75)              0                              0
  6wk                                                                                              2 (50)            21.5 ± 2.1        34.6 ± 2.5               35.0 ± 1.8                                                      1.6 ± 1.7             4.6        0.4                        1.9               0 (0)                      1 (50)              1 (50)                         0
  \(6\) 8--12 × 1 min intervals × 4/wk, 3 wk ([@B51])                                                                                                                                                                                                                                                                                                                                       
  UBC                                                                                                                                                                                                                                                                                                                                                                                       
  \(1\) 4--10 × 1 min × 3/wk, 12 wk ([@B24])                                                       34 (69)           55.3 ± 13.6       33.4 ± 6.6               22.1 ± 7.3                                                      2.2 ± 2.0             6.6        \< 0.001 (*d* = 0.3)       1.2               4 (12)                     8 (24)              22 (64)                        0
  \(2\) Up to 1 min intervals × 3/wk, 3 wk ([@B23])                                                4 (100)           21.5 ± 4.4        NA                       40.1 ± 7.7                                                      3.6 ± 3.0             8.9        0.1                        2.2               1 (25)                     2 (50)              1 (25)                         0
  **MICT**                                                                                         **262 (26)**      **62.0 ± 12.1**   **27.6 ± 5.3**           **27.5 ± 8.1**                                                  **2.5 ± 3.8**         **9.1**    **\< 0.001 (*d* = 0.3)**   **1.5**           **55 (21)**                **89 (34)**         **110 (42)**                   **8 (3)**
  UQ                                                                                                                                                                                                                                                                                                                                                                                        
  \(1\) 30 min × 5/wk, 16 wk ([@B54])                                                              25 (32)           54.5 ± 9.6        32.5 ± 6.0               27.5 ± 8.0                                                      1.4 ± 5.6             5.1        0.2                        1.5               4 (16)                     5 (20)              13 (52)                        3 (12)
  \(2\) 40 min × 3/wk, 12 wk ([@B61])                                                              39 (18)           65.3 ± 6.8        26.9 ± 2.3               27.4 ± 7.5                                                      1.9 ± 4.0             6.9        \< 0.01 (*d* = 0.2)        1.5               7 (18)                     11 (28)             19 (49)                        2 (5)
  \(3\) 22.5 min + 30 min strength × 2/wk and 52.5 min × 2/wk, 8 wk                                20 (8)            60.5 ± 7.0        30.6 ± 10.2              25.4 ± 6.6                                                      0.2 ± 2.0             0.8        0.7                        1.4               0                          3 (15)              17 (85)                        0
  Antwerp/Leuven                                                                                                                                                                                                                                                                                                                                                                            
  \(1\) 47 min × 3/wk, 12 wk ([@B47])                                                              91 (10)           57.9 ± 8.7        28.3 ± 4.3               22.7 ± 5.6                                                      4.3 ± 3.25            18.9       \< 0.001 (*d* = 0.7)       1.3               33 (36)                    34 (38)             24 (27)                        0
  NTNU                                                                                                                                                                                                                                                                                                                                                                                      
  \(1\) 50 min × 2/wk, 12 mth ([@B60])                                                             77 (45)           72.5 ± 2.1        24.7 ± 2.9               31.1 ± 5.9                                                      1.5 ± 3.4             4.8        \< 0.001 (*d* = 0.2)       1.7               10 (13)                    28 (36)             36 (47)                        3 (4)
  Queens                                                                                                                                                                                                                                                                                                                                                                                    
  \(1\) 30 min × 4/wk, 4wk                                                                         10 (0)            23.1 ± 5.3        25.9 ± 4.4               47.2 ± 5.7                                                      4.0 ± 2.2             8.5        \< 0.001 (*d* = 0.8)       2.6               2 (20)                     7 (70)              1 (10)                         0
  **Total**                                                                                        **677 (27)**      **56.3 ± 16.0**   **27.8 ± 5.3**           **29.7 ± 10.5**                                                 **2.8 ± 3.9**         **9.4**    **\< 0.001 (*d* = 0.3)**   **1.7**           **162 (24)**               **229 (34)**        **274 (40)**                   **12 (2)**

∗

Values shown are mean ± standard deviation (SD). Number of participants (n), percentage (%), body mass index (BMI),

O

2peak

(peak aerobic fitness), weeks (wk), minutes (min), technical error of measurement (TEM), female (F), maximal steady state (MSS).

∗∗

The TEM for each individual study was different to the average TEM for each of the three training groups (high-volume HIIT, low-volume HIIT/SIT and MICT).

Absolute ![](fphys-10-00019-i001.jpg)O~2peak~
---------------------------------------------

Absolute ![](fphys-10-00019-i001.jpg)O~2peak~ values were significantly increased after all intervention types ([Table 4](#T4){ref-type="table"}). There were small effect sizes after high-volume HIIT (0.27 L/min, 95% CI −0.33 to --0.23, *P* \< 0.001) Cohen's *d* = 0.3; MICT (0.19 L/min, 95% CI −0.24 to −0.12, *P* \< 0.001) Cohen's *d* = 0.2; and low-volume HIIT/SIT (0.16 L/min, 95% CI −0.22 to −0.10 to, *P* \< 0.001) Cohen's *d* = 0.2. [Table 4](#T4){ref-type="table"} presents the adjusted group means. Small significant group differences were found with ANCOVA for the change in absolute ![](fphys-10-00019-i001.jpg)O~2peak~ between high-volume and low-volume HIIT/SIT (0.12 L/min, 95% CI 0.02 to 0.22 L/min, *P* \< 0.05) and between high-volume HIIT and MICT (0.09 mL/kg/min, 95% CI 0.02 to 0.17 L/min, *P* = 0.01). There was no significant difference (*P* = 0.61) between MICT and low-volume HIIT/SIT (−0.02 L/min, 95% CI −0.13 to 0.08 L/min).

Different Populations
---------------------

There was a significant difference between the increases in men and women's absolute ![](fphys-10-00019-i001.jpg)O~2peak~ values in high-volume HIIT. Men had a greater (*P* \< 0.01) increase (0.49 L/min, 95% CI 0.26 to 0.38) compared to women (0.15 L/min, 95% CI 0.09 to 0.21). There were no other significant differences between men and women's relative and absolute ![](fphys-10-00019-i001.jpg)O~2peak~ responses to high-volume HIIT, low-volume HIIT/SIT or MICT.

[Table 5](#T5){ref-type="table"} shows that when analyzed according to the population type, middle-aged and elderly participants had a significantly greater (*P* \< 0.001) increase in relative ![](fphys-10-00019-i001.jpg)O~2peak~ with high-volume HIIT than MICT. Young and healthy participants responded significantly more favorably (*P* \< 0.05) to MICT than low-volume HIIT/SIT and high-volume HIIT. Participants with coronary artery disease and middle-aged and elderly participants in the high-volume HIIT group had a ![](fphys-10-00019-i001.jpg)O~2peak~ response greater than the MCID. Those with coronary artery disease and young and healthy participants also had a ![](fphys-10-00019-i001.jpg)O~2peak~ response greater than the MCID with MICT. All other population groups and training interventions failed to reach the MCID.

###### 

Adjusted means for absolute and relative ![](fphys-10-00019-i001.jpg)O~2peak~ response.

                     Relative mean   Absolute                 
  ------------------ --------------- ---------- ------------- ------------
  High-volume HIIT   3.3 ± 3.7       2.9--3.7   0.29 ± 0.40   0.25--0.34
  Low-volume HIIT    2.5 ± 4.1       1.7--3.3   0.18 ± 0.44   0.09--0.26
  MICT               2.4 ± 3.8       2.0--2.9   0.20 ± 0.42   0.15--0.26

∗

Adjusted for sex, age, individual study, study duration, sessions per week, population group and the average between pre and post-test scores.

∗∗

Adjusted for sex, age, individual study, study duration, sessions per week, population group, baseline weight, and the average between pre and post-test scores and the pre weight.

###### 

![](fphys-10-00019-i001.jpg)O~2peak~ response in different population groups.

                                               Relative ![](fphys-10-00019-i001.jpg)O~2peak~                 
  -------------------------------------------- ----------------------------------------------- ------------- -------------
  Coronary artery disease                      4.19 ± 4.12                                     NA            3.59 ± 3.66
  Type II diabetes and/or metabolic syndrome   2.73 ± 4.13                                     1.86 ± 4.07   0.95 ± 4.01
  Middle-aged and elderly                      4.50 ± 3.93ˆ                                    NA            1.50 ± 3.36
  Young and healthy                            1.10 ± 3.11^∗^                                  2.28 ± 3.53   4.02 ± 2.23

Not assessed due to no participants (NA). Significantly different to MICT

∗

P \< 0.05, ˆP \< 0.001.

Overall, the covariates examined (sex, age, individual study, study duration, sessions per week, population group and the average between pre and post-test scores) contributed to 17.3% of the change in relative ![](fphys-10-00019-i001.jpg)O~2peak~ (*P* \< 0.001). Individual studies had the largest impact, explaining 13.5% of ![](fphys-10-00019-i001.jpg)O~2peak~ response (*P* \< 0.001).

Categories of ![](fphys-10-00019-i001.jpg)O~2peak~ Responders
-------------------------------------------------------------

[Table 3](#T3){ref-type="table"} and [Figure 2](#F2){ref-type="fig"} outlines the thresholds and percentages of likely responders, likely non-responders, likely adverse responders and those uncertain (not classified as a likely responder or likely non-responder) for each training intervention, and the individual studies contributing to these training interventions. High-volume HIIT had significantly more likely responders (31%) compared to MICT (21%) and low-volume HIIT/SIT (16%), *P* \< 0.01. There were comparable responders classified as uncertain (∼33%) across high-volume HIIT, low-volume HIIT/SIT and MICT. On average, high-volume HIIT had a greater training load (∼100 Arbitrary Units (AU)) compared to low-volume HIIT/SIT (∼33 AU) and MICT (∼75 AU).

![Percentage of likely responders to changes in relative ![](fphys-10-00019-i001.jpg)O~2peak~ in each training intervention.](fphys-10-00019-g002){#F2}

Studies with short durations (3--4 weeks) had fewer likely responders (13% average) irrespective of whether the intervention was high-volume HIIT, low-volume HIIT/SIT or MICT ([@B15]; [@B39]; [@B59]; [@B12], [@B11]; [@B51]; [@B69]). Participants from the shorter duration studies were younger (mean - 23.1 years) and had a higher ![](fphys-10-00019-i001.jpg)O~2peak~ (44.4 mL/kg/min) prior to the intervention ([@B60]; [@B33]). From the individual studies over 4 weeks in duration, the study ([@B33]) with the most likely responders (53%) had the greatest average training load per session (up to ∼ 150 AU), the longest-running intervention (2 years) and the most training sessions each week (up to five). Most studies had three training sessions per week with 28% of participants classified as a likely responder ([@B60]; [@B47]; [@B54]; [@B23]; [@B24]; [@B69]). One study had two sessions each week, with 13% of participants classified as a likely responder ([@B60]).

Studies with middle-aged (50--60 years) and elderly participants (70+ years) had significantly (*P* \< 0.001) more likely responders with high-volume HIIT (44% average) compared to MICT (13% average) ([@B60]; [@B33]). Studies with coronary artery disease participants had comparable likely responders with high-volume HIIT (38% average) and MICT (27% average), *P* = 0.06 ([@B47]; [@B61]). Those with metabolic syndrome and/or type-2 diabetes ([@B54]; [@B24]) had significantly more likely responders with high-volume HIIT (34% average) compared to low-volume HIIT/SIT (17% average) and MICT (8% average), *P* \< 0.001. Likely adverse responders were from studies with elderly participants; three participants came from a MICT intervention ([@B60]) and two participants came from a high-volume HIIT intervention ([@B60]). Likely adverse responders also included one participant with coronary artery disease from a high-volume HIIT intervention and two from a MICT intervention ([@B47]), and one participant with metabolic syndrome from a high-volume HIIT intervention and 1 from a MICT intervention ([@B54]).

Discussion
==========

Establishing a dose (i.e., intensity, frequency and duration) of exercise training that improves the number of observed responders with a clinically meaningful improvement to exercise training may reduce the prevalence of chronic disease risk and all-cause mortality associated with a low cardiorespiratory fitness. However, much of the research-to-date has focused largely on group-mean changes, with minimal studies comparing interventions and clinically meaningful responses. Furthermore, many of these studies have been small in sample size (between 10 and 20 participants), with potentially large variations in participant baseline physical activity levels, and training responses that are statistically underpowered. With personalized medicine becoming increasingly widespread, the aim of this study was to compare, in a relatively large sample size (*n* = 677) from different laboratories, the observed rates of likely responders between a variety of aerobic training interventions. Our study adds to the current literature by showing high-volume HIIT has significantly more likely responders compared to low-volume HIIT/SIT and MICT.

Meta-analyses have shown that high-volume HIIT is comparable, if not superior, to MICT for improving CRF (![](fphys-10-00019-i001.jpg)O~2max~/![](fphys-10-00019-i001.jpg)O~2peak~) and other health biomarkers ([@B25]; [@B65]; [@B42]; [@B52]; [@B9]). The group mean changes from this study were similar to previous research indicating that high-volume HIIT had a larger mean ![](fphys-10-00019-i001.jpg)O~2peak~ gain than MICT and low-volume HIIT/SIT and studies with the greatest ![](fphys-10-00019-i001.jpg)O~2peak~ gains used longer high intensity intervals/high-volume HIIT ([@B4]). Despite these group mean changes, there was considerable heterogeneity in ![](fphys-10-00019-i001.jpg)O~2peak~ responses in each intervention ([Figure 3](#F3){ref-type="fig"}). An approach to assess whether the inter-individual training response is true that has gained much support involves comparing the adjusted standard deviations between the training group and a control comparator group ([@B3]; [@B68]). If the standard deviation of the training group is clinically significant and larger than the control group, it can be assumed that a true individual response has occurred. Because our data did not include a control comparator group, we felt this approach was not warranted. Nonetheless, when looking at the standard deviation changes of the adjusted group means, they were all greater than the MCID (3.5 mL/kg/min). Overall, the number of "responders" for each intervention was slightly lower in comparison to previous reports ([@B58]; [@B27]; [@B29]). However, many studies to-date have based thresholds for response on a percentage of change or one TEM away from zero; a lower threshold will produce more "responders" ([@B58]; [@B27]; [@B29]). Furthermore, these studies have predominantly examined healthy but sedentary populations, whereas our data had a mix of clinical and healthy populations ([@B63]; [@B58]; [@B27]; [@B29]). For example, our data demonstrated that participants with coronary artery disease and middle-aged and elderly participants in the high-volume HIIT group had a ![](fphys-10-00019-i001.jpg)O~2peak~ response greater than the MCID. Those with coronary artery disease and young and healthy participants also had a ![](fphys-10-00019-i001.jpg)O~2peak~ response greater than the MCID with MICT. All other population groups and training interventions failed to reach the MCID. Middle-aged adults and the elderly, participants with type II diabetes and/or metabolic syndrome had a greater proportion of responders with high-volume HIIT; whereas response rates between exercise training loads were similar in participants with coronary artery disease and those who were young and healthy. There were 4 participants from our data that were classified as "likely adverse responders"; rather than a true adverse response, these participants may have performed poorly on the testing day.

![Waterfall plots of the relative ![](fphys-10-00019-i001.jpg)O~2peak~ (mL/kg/min) response rates for each intervention (raw data).](fphys-10-00019-g003){#F3}

It has been argued that some people are "dose-sensitive" as opposed to a "non-responder" ([@B43]; [@B68]). If physiological systems are maximized, it seems possible that everyone can improve their ![](fphys-10-00019-i001.jpg)O~2peak~ ([@B4]; [@B34]; [@B43]). A clinically meaningful ![](fphys-10-00019-i001.jpg)O~2peak~ response is unlikely if maximal stroke volume, oxygen transport and oxygen utilization does not improve ([@B57]). Furthermore, exercise can alter the expression of genes related to mitochondrial function and energy use ([@B7]; [@B17]). Methylation can increase gene expression and affect metabolic adaptions in skeletal muscle ([@B7]). In skeletal muscle, most genes related to metabolism are demethylated following long-term exercise training ([@B64]). These changes appear to be dose dependent and transient, with higher intensity exercise (80% heart rate maximum) causing greater demethylation and gene expression compared to lower-intensity exercise (40% heart rate maximum) where the total volume of exercise (caloric expenditure) is similar ([@B7]). To summarize, a higher training load may be more effective in those "dose sensitive" or those considered a "low responder" to training because participants are working at a threshold high enough to activate certain genes and molecular pathways required to induce a clinically meaningful exercise training response ([@B40]). Our analysis demonstrated that studies with the longest duration intervention and highest overall training loads produced the greatest ![](fphys-10-00019-i001.jpg)O~2peak~ gains and more likely responders ([@B60]; [@B47]; [@B33]). Typically these studies included high-volume HIIT. Our results complement previous research that indicates a greater training load correlates with fewer non-responders. For example, a recent study on 78 young males found that when training was increased from 60 to 180 min to 240--300 min per week, the number of responders (1 × technical error of measurement relative to zero) increased from 30--71 to 100%, respectively, ([@B43]). It would be interesting to see if those who were deemed a "likely non-responder" from our analysis would "respond" with an increase in training duration, frequency or intensity.

Our analysis showed that age, sex, the individual study, study duration, number of sessions each week, the population group and the average between pre and post-test scores predicted 17.3% of the variance in training response; with the individual study being the highest predictor (13.5%) for ![](fphys-10-00019-i001.jpg)O~2peak~ response. This suggests there were other more substantial factors that affected ![](fphys-10-00019-i001.jpg)O~2peak~ trainability. In the HERITAGE study, 15% of the variation in the response to MICT was attributed to baseline ![](fphys-10-00019-i001.jpg)O~2peak~, age, sex, body mass and ethnicity combined; with approximately 6% attributed to workload fluctuations, 20% to technical error and daily changes, and up to 50% to genetic make-up ([@B57]). A systematic review from our group identified 97 genetic variants that have been associated with ![](fphys-10-00019-i001.jpg)O~2peak~ trainability ([@B67]). It would be interesting to explore if those classified as a likely non-responder within our study have common genetic variants that may contribute to them being "dose sensitive". This will be investigated in our PREDICT-HIIT Study by combining the ![](fphys-10-00019-i001.jpg)O~2peak~ data presented here with genetic analyses.

Although there were several limitations to our study, the heterogeneity of the participants and training approaches should improve external ecological validity. Combining meaningful data from small, individual studies, as we have presented here, is necessary if we seek robust, reproducible, and translational results in exercise science ([@B22]). Data was collated from 18 different studies with different protocols and equipment for testing. Participants were predominantly males, training status varied between studies (active vs. sedentary populations), and there was a mixture of clinical (CAD, diabetes, metabolic syndrome) and healthy populations. The age (between groups, 18--81 years), volume of work (60 min to 4 min and 50% heart rate peak to 170% work rate peak) and overall duration (3 to 104 weeks) varied considerably for the individual studies included in the current analysis. These factors are very likely to contribute to training response. Furthermore, some of the individual studies did not control for variables like diet, medication use, smoking status, sleep and recovery time. Lack of sleep or poor nutrition may negatively affect the intensity an individual can train and how fast they can recover between sessions; possibly combining to reduce training response through several interactions, such as genetic and epigenetic changes ([@B62]; [@B64]; [@B28]; [@B48]; [@B70]). Our TEM was calculated using one that has been previously published ([@B36]). A more robust approach is to measure an individual's ![](fphys-10-00019-i001.jpg)O~2peak~ response in a test-retest study ([@B30]) or with a time-matched control group. This information was not collected for each individual intervention from our study. We also acknowledge that our research focuses on several select studies and represents a small portion of MICT, HIIT and SIT related literature. Finally, adherence to the exercise training prescription has been found to impact on studies comparing HIIT to MICT ([@B47]; [@B21]). In these studies people allocated to the HIIT group did not meet the target exercise intensities and those in the MICT group trained at a higher intensity. In our analysis we have not taken this into account and used an intention to treat analysis approach with the belief that it would be more externally valid.

Future research with cross-over designs will determine if a participant may have a better response to an alternative intervention. Such a design is costly and seldom used but potentially decreases the random variation that may occur from comparing just one pre and post-test score, and measures how an individual will respond to different training interventions ([@B28]). A recent cross over study ([@B12]) compared the number of responders to SIT with MICT. Participants (*n* = 21) had to complete four sessions a week of SIT or MICT (separated by a 3-month washout period). Both interventions produced similar group mean changes in ![](fphys-10-00019-i001.jpg)O~2peak~, and similar rates of response (based on 2 × TEM). Some individuals responded to MICT, but not to SIT and vice versa; whereas others did not improve their ![](fphys-10-00019-i001.jpg)O~2peak~ in either intervention ([@B12]). Thus, those who fail to have a clinically meaningful ![](fphys-10-00019-i001.jpg)O~2peak~ response to an exercise training approach within our study may benefit from another form of training.

In conclusion, high-volume HIIT had a greater average training load and significantly more likely responders compared to low-volume HIIT/SIT and MICT. Individual studies with the smallest duration and training loads generally had the least significant gains and fewer clinically meaningful ![](fphys-10-00019-i001.jpg)O~2peak~ responders. Future large, well-controlled studies with comparator groups and cross-over designs may help to identify influential variables and the ideal training load for ![](fphys-10-00019-i001.jpg)O~2peak~ trainability.
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